{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:01:32Z","timestamp":1784127692920,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the Guangdong Basic and Applied Basic Research Foundation","award":["No. 2023A1515010235 and 2025A1515011140"],"award-info":[{"award-number":["No. 2023A1515010235 and 2025A1515011140"]}]},{"name":"Start-up Fund for High-level Talents in Affiliated Hospital of Guangdong Medical University","award":["No. 51301Z20200007"],"award-info":[{"award-number":["No. 51301Z20200007"]}]},{"name":"Medical Science and Technology Research Project of Guangdong Province","award":["No. B2021180"],"award-info":[{"award-number":["No. B2021180"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05531-z","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:34:19Z","timestamp":1775900059000},"page":"2193-2208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulation of EMT and cholangiocarcinoma metastasis by KIN17 through the mTOR signaling pathway"],"prefix":"10.1007","volume":"481","author":[{"given":"Yuxia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lok Ting","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"5531_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.suc.2018.12.004","volume":"99","author":"AS Khan","year":"2019","unstructured":"Khan AS, Dageforde LA (2019) Cholangiocarcinoma. Surg Clin North Am 99:315\u2013335. https:\/\/doi.org\/10.1016\/j.suc.2018.12.004","journal-title":"Surg Clin North Am"},{"key":"5531_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jmri.24810","volume":"42","author":"KS Jhaveri","year":"2015","unstructured":"Jhaveri KS, Hosseini-Nik H (2015) MRI of cholangiocarcinoma. J Magn Reson Imaging 42:1165\u20131179. https:\/\/doi.org\/10.1002\/jmri.24810","journal-title":"J Magn Reson Imaging"},{"key":"5531_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ncpgasthep0389","volume":"3","author":"T Patel","year":"2006","unstructured":"Patel T (2006) Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3:33\u201342. https:\/\/doi.org\/10.1038\/ncpgasthep0389","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5531_CR4","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi M, Vithayathil M, Khan SA (2025) Epidemiology of cholangiocarcinoma. Eur J Surg Oncol 51:107064. https:\/\/doi.org\/10.1016\/j.ejso.2023.107064","journal-title":"Eur J Surg Oncol"},{"key":"5531_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma-evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157","journal-title":"Nat Rev Clin Oncol"},{"key":"5531_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2005.03.040","volume":"128","author":"KN Lazaridis","year":"2005","unstructured":"Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma Gastroenterol 128:1655\u20131667. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.040","journal-title":"Cholangiocarcinoma Gastroenterol"},{"key":"5531_CR7","first-page":"306","volume":"5","author":"PJ Thuluvath","year":"1997","unstructured":"Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306\u2013315","journal-title":"Gastroenterologist"},{"key":"5531_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C Raggi","year":"2022","unstructured":"Raggi C, Taddei ML, Rae C, Braconi C, Marra F (2022) Metabolic reprogramming in cholangiocarcinoma. J Hepatol 77:849\u2013864. https:\/\/doi.org\/10.1016\/j.jhep.2022.04.038","journal-title":"J Hepatol"},{"key":"5531_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/s1072-7515(98)00207-5","volume":"187","author":"S Iwatsuki","year":"1998","unstructured":"Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187:358\u2013364. https:\/\/doi.org\/10.1016\/s1072-7515(98)00207-5","journal-title":"J Am Coll Surg"},{"key":"5531_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000488342","volume":"36","author":"SH Loosen","year":"2018","unstructured":"Loosen SH, Vucur M, Trautwein C, Roderburg C, Luedde T (2018) Circulating Biomarkers for Cholangiocarcinoma. Dig Dis 36:281\u2013288. https:\/\/doi.org\/10.1159\/000488342","journal-title":"Dig Dis"},{"key":"5531_CR11","doi-asserted-by":"publisher","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, Youssef BM, Klimstra D, Blumgart LH (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507\u2013517; discussion 517-9. https:\/\/doi.org\/10.1097\/00000658-200110000-00010","DOI":"10.1097\/00000658-200110000-00010"},{"key":"5531_CR12","doi-asserted-by":"publisher","unstructured":"Mosconi S, Beretta GD, Labianca R, Zampino MG, Gatta G, Heinemann V (2009) Cholangiocarcinoma. Crit Rev Oncol Hematol 69:259\u2009\u20132\u200970. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.09.008","DOI":"10.1016\/j.critrevonc.2008.09.008"},{"key":"5531_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham Sand Gores GJ (2021) Cholangiocarcinoma. Nat Rev Dis Primers 7:65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2","journal-title":"Nat Rev Dis Primers"},{"key":"5531_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2017.03.026","volume":"67","author":"SI Ilyas","year":"2017","unstructured":"Ilyas SI, Gores GJ (2017) Emerging molecular therapeutic targets for cholangiocarcinoma. J Hepatol 67:632\u2013644. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.026","journal-title":"J Hepatol"},{"key":"5531_CR15","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1093\/nar\/22.20.4335","volume":"22","author":"A Mazin","year":"1994","unstructured":"Mazin A, Timchenko T, Menissier-de Murcia J, Schreiber V, Angulo JF, de Murcia G, Devoret R (1994) Kin17, a mouse nuclear zinc finger protein that binds preferentially to curved DNA. Nucleic Acids Res 22:4335\u20134341. https:\/\/doi.org\/10.1093\/nar\/22.20.4335","journal-title":"Nucleic Acids Res"},{"key":"5531_CR16","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3892\/ol.2017.5707","volume":"13","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Huang S, Gao H, Wu K, Ouyang X, Zhu Z, Yu X, Zeng T (2017) Upregulation of KIN17 is associated with non-small cell lung cancer invasiveness. Oncol Lett 13:2274\u20132280. https:\/\/doi.org\/10.3892\/ol.2017.5707","journal-title":"Oncol Lett"},{"key":"5531_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/mc.23492","volume":"62","author":"Z Dai","year":"2023","unstructured":"Dai Z, Huang Q, Huang X, Zhu C, Zahid KR, Liu T, Li Q, Wu C, Peng M, Xiao X, Raza U, Yu N, Zeng T (2023) KIN17 promotes cell migration and invasion through stimulating the TGF-beta\/Smad2 pathway in hepatocellular carcinoma. Mol Carcinog 62:369\u2013384. https:\/\/doi.org\/10.1002\/mc.23492","journal-title":"Mol Carcinog"},{"key":"5531_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11010-020-03939-9","volume":"476","author":"QG Jiang","year":"2021","unstructured":"Jiang QG, Xiong CF, Lv YX (2021) Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway. Mol Cell Biochem 476:727\u2013739. https:\/\/doi.org\/10.1007\/s11010-020-03939-9","journal-title":"Mol Cell Biochem"},{"key":"5531_CR19","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/1759-7714.14004","volume":"12","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zahid KR, Chen J, Pang X, Zhong M, Huang H, Pan W, Yin J, Raza U, Zeng J, Zhu X, Zeng T (2021) KIN17 promotes tumor metastasis by activating EMT signaling in luminal-A breast cancer. Thorac Cancer 12:2013\u20132023. https:\/\/doi.org\/10.1111\/1759-7714.14004","journal-title":"Thorac Cancer"},{"key":"5531_CR20","doi-asserted-by":"publisher","unstructured":"Li Q, Yang Y, Lin X, Chu LT, Chen H, Chen L, Tang J, Zeng T (2025) Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K\/AKT\/mTOR signaling pathway. Oncol Rep 53. https:\/\/doi.org\/10.3892\/or.2025.8864","DOI":"10.3892\/or.2025.8864"},{"key":"5531_CR21","first-page":"607","volume":"13","author":"M Zhong","year":"2020","unstructured":"Zhong M, Liu Z, Wu K, Hong Z, Zhang Y, Qu J, Zhu C, Ou Z, Zeng T (2020) Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-kappaB-Snail pathway. Int J Clin Exp Pathol 13:607\u2013615","journal-title":"Int J Clin Exp Pathol"},{"key":"5531_CR22","doi-asserted-by":"publisher","first-page":"e25343","DOI":"10.1371\/journal.pone.0025343","volume":"6","author":"T Zeng","year":"2011","unstructured":"Zeng T, Gao H, Yu P, He H, Ouyang X, Deng L, Zhang Y (2011) Up-regulation of kin17 is essential for proliferation of breast cancer. PLoS ONE 6:e25343. https:\/\/doi.org\/10.1371\/journal.pone.0025343","journal-title":"PLoS ONE"},{"key":"5531_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C (2019) EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol 29:212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001","journal-title":"Trends Cell Biol"},{"key":"5531_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V (2018) Epithelial Mesenchymal Transition in Tumor Metastasis. Annu Rev Pathol 13:395\u2013412. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043854","journal-title":"Annu Rev Pathol"},{"key":"5531_CR25","doi-asserted-by":"publisher","unstructured":"Zhou X, Li Y, Yang C, Chen D, Wang T, Liu T, Yan W, Su Z, Peng B, Ren X(2023)Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A \/ mTOR\/SREBP1 axis in cholangiocarcinoma. Life Sci 327:121698. https:\/\/doi.org\/10.1016\/j.lfs.2023.121698","DOI":"10.1016\/j.lfs.2023.121698"},{"key":"5531_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y (2019) Targeting mTOR for cancer therapy. J Hematol Oncol 12:71. https:\/\/doi.org\/10.1186\/s13045-019-0754-1","journal-title":"J Hematol Oncol"},{"key":"5531_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10585-012-9526-9","volume":"30","author":"SM Hong","year":"2013","unstructured":"Hong SM, Park CW, Cha HJ, Kwon JH, Yun YS, Lee NG, Kim DG, Nam HG, Choi KY (2013) Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma. Clin Exp Metastasis 30:177\u2013187. https:\/\/doi.org\/10.1007\/s10585-012-9526-9","journal-title":"Clin Exp Metastasis"},{"key":"5531_CR28","doi-asserted-by":"publisher","unstructured":"Joechle K, Jumaa H, Thriene K, Hellerbrand C, Kulemann B, Fichtner-Feigl S, Lang SA, Guenzle J (2021) Dual Inhibition of mTORC1\/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases. Front Cell Dev Biol 9:785979. https:\/\/doi.org\/10.3389\/fcell.2021.785979","DOI":"10.3389\/fcell.2021.785979"},{"key":"5531_CR29","doi-asserted-by":"publisher","first-page":"19268","DOI":"10.1038\/s41598-021-98948-z","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Liu C, Wang M, Sun D, Zhu P, Zhang P, Tan X, Shi G (2021) Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. Sci Rep 11:19268. https:\/\/doi.org\/10.1038\/s41598-021-98948-z","journal-title":"Sci Rep"},{"key":"5531_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00210-020-01885-3","volume":"393","author":"R Jaidee","year":"2020","unstructured":"Jaidee R, Kongpetch S, Senggunprai L, Prawan A, Kukongviriyapan U, Kukongviriyapan V (2020) Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways. Naunyn Schmiedebergs Arch Pharmacol 393:1681\u20131690. https:\/\/doi.org\/10.1007\/s00210-020-01885-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5531_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X (2022) The molecular mechanisms and therapeutic strategiesof EMT in tumor progression and metastasis. J Hematol Oncol 15:129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"J Hematol Oncol"},{"key":"5531_CR32","doi-asserted-by":"publisher","unstructured":"Yang S, Zou R, Dai Y, Hu Y, Li F, Hu H (2023) Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). Int J Oncol 63. https:\/\/doi.org\/10.3892\/ijo.2023.5585","DOI":"10.3892\/ijo.2023.5585"},{"key":"5531_CR33","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s13577-024-01096-5","volume":"37","author":"X Huang","year":"2024","unstructured":"Huang X, Dai Z, Zeng B, Xiao X, Zahid KR, Lin X, Liu T, Zeng T (2024) KIN17 functions in DNA damage repair and chemosensitivity by modulating RAD51 in hepatocellular carcinoma. Hum Cell 37:1489\u20131504. https:\/\/doi.org\/10.1007\/s13577-024-01096-5","journal-title":"Hum Cell"},{"key":"5531_CR34","unstructured":"Liu B, Wu XP, Wang ZM et al (1999) Preliminary observation of a newly established hepatocellular carcinoma cell line (HCC-9810). J Shandong Med Univ 37(4) :349\u2013350 (in Chinese)"},{"issue":"9","key":"5531_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11626-997-0125-z","volume":"33","author":"M Enjoji","year":"1997","unstructured":"Enjoji M, Sakai H, Nawata H, Kajiyama K, Tsuneyoshi M (1997) Sarcomatous and adenocarcinoma cell lines from the same nodule of cholangiocarcinoma. Vitro Cell Dev Biol Anim 33(9):681\u2013683. https:\/\/doi.org\/10.1007\/s11626-997-0125-z","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"5531_CR36","unstructured":"Wang SG, Han BL, Duan HC et al (1997) Establishment of an extrahepatic cholangiocarcinoma cell line. Chin J Experimental Surg 14(2):67\u201368 (in Chinese)"},{"issue":"6","key":"5531_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02623562","volume":"25","author":"M Miyagiwa","year":"1989","unstructured":"Miyagiwa M, Ichida T, Tokiwa T, Sato J, Sasaki H (1989) A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19\/9 in serum-free medium. Vitro Cell Dev Biol 25(6):503\u2013510. https:\/\/doi.org\/10.1007\/BF02623562","journal-title":"Vitro Cell Dev Biol"},{"key":"5531_CR38","doi-asserted-by":"publisher","unstructured":"Manfioletti G, Fedele M (2023) Epithelial-Mesenchymal Transition (EMT). Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241411386","DOI":"10.3390\/ijms241411386"},{"key":"5531_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-023-02656-7","volume":"42","author":"C Hu","year":"2023","unstructured":"Hu C, Xin Z, Sun X, Hu Y, Zhang C, Yan R et al (2023) Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress. J Exp Clin Cancer Res 42:108. https:\/\/doi.org\/10.1186\/s13046-023-02656-7","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05531-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:43Z","timestamp":1778916523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05531-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5531"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05531-z","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}